Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gordon Frankle

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Synapse (New York, N.Y.)|March 1, 2017
Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [<sup>11</sup> C]PBR28W Gordon Frankle, Rajesh Narendran, Andrew T Wood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
Archives of General Psychiatry|March 3, 2010
Increased synaptic dopamine function in associative regions of the striatum in schizophreniaLawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
The American Journal of Psychiatry|December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersRajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2012
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907Nina Bl Urban, Ragy R Girgis, Peter S Talbot, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
Psychopharmacology|September 6, 2006
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635W Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Synapse (New York, N.Y.)|March 1, 2017
Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [<sup>11</sup> C]PBR28W Gordon Frankle, Rajesh Narendran, Andrew T Wood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
Archives of General Psychiatry|March 3, 2010
Increased synaptic dopamine function in associative regions of the striatum in schizophreniaLawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
The American Journal of Psychiatry|December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersRajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2012
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907Nina Bl Urban, Ragy R Girgis, Peter S Talbot, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
Psychopharmacology|September 6, 2006
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635W Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 5